Altogether, these differences indicate that the HSD3B1 c.1100 genotypes, albeit exhibiting limited change in individual genes, had a significant impact on signaling pathways and immune regulatory pathways in a tumor-site-specific manner. The gene discussed is HSD3B1; the disease is neoplasm.